EQUITY RESEARCH MEMO

STARSURGICAL

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)55/100

Starsurgical, Inc. is a privately-held medical device company based in Portland, Oregon, specializing in innovative solutions for complex abdominal wall closures. Founded in 1990, the company has established itself as a niche provider in the surgical market, addressing challenging complications such as open abdominal wounds and difficult wound closures. Its flagship products include the Wittmann Patch, a device designed for temporary abdominal closure that allows for repeated access and gradual closure, and the TAWT Retention Guard system, which secures retention sutures to prevent tissue damage. These products serve a specific and often unmet need in trauma and general surgery, particularly in cases where traditional closure methods are not viable. As a private company, Starsurgical has maintained a focused product portfolio and a reputation for quality in a specialized segment of the medical device industry. Despite being in operation for over three decades, the company remains relatively small and has not disclosed recent funding or valuation data, suggesting a conservative growth strategy or limited external investment interest. However, its products are well-regarded in the surgical community, and the ongoing demand for solutions in complex abdominal wall management positions the company for steady, if not explosive, growth.

Upcoming Catalysts (preview)

  • Q4 2026New product launch or next-generation Wittmann Patch40% success
  • Q2 2027Distribution partnership or licensing agreement30% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)